Nea Management 13F annual report
Nea Management is an investment fund managing more than $1.33 trillion ran by Stephanie Brecher. There are currently 41 companies in Mrs. Brecher’s portfolio. The largest investments include Arcellx Inc and Tempus Ai Inc, together worth $367 billion.
$1.33 trillion Assets Under Management (AUM)
As of 7th August 2024, Nea Management’s top holding is 3,745,262 shares of Arcellx Inc currently worth over $207 billion and making up 15.6% of the portfolio value.
In addition, the fund holds 4,572,810 shares of Tempus Ai Inc worth $160 billion.
The third-largest holding is Rhythm Pharmaceuticals worth $119 billion and the next is Savara Inc worth $98.6 billion, with 24,471,264 shares owned.
Currently, Nea Management's portfolio is worth at least $1.33 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Nea Management
The Nea Management office and employees reside in Timonium, Maryland. According to the last 13-F report filed with the SEC, Stephanie Brecher serves as the Chief Legal Officer at Nea Management.
Recent trades
In the most recent 13F filing, Nea Management revealed that it had opened a new position in
Tempus Ai Inc and bought 4,572,810 shares worth $160 billion.
The investment fund also strengthened its position in Savara Inc by buying
333,333 additional shares.
This makes their stake in Savara Inc total 24,471,264 shares worth $98.6 billion.
Savara Inc soared 8.4% in the past year.
On the other hand, there are companies that Nea Management is getting rid of from its portfolio.
Nea Management closed its position in Mirum Pharmaceuticals Inc on 14th August 2024.
It sold the previously owned 4,186,243 shares for $101 billion.
Stephanie Brecher also disclosed a decreased stake in Arcellx Inc by 0.2%.
This leaves the value of the investment at $207 billion and 3,745,262 shares.
One of the largest hedge funds
The two most similar investment funds to Nea Management are Hps Investment Partners and Galileo (ptc) Ltd. They manage $1.33 trillion and $1.33 trillion respectively.
Stephanie Brecher investment strategy
Nea Management’s portfolio is diversified across 4 sectors.
Currently, their heaviest sector is Health Care — making up 48.1% of
the total portfolio value.
The fund focuses on investments in the United States as
48.8% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
17% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $555 million.
The complete list of Nea Management trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Arcellx Inc |
21.07%
3,745,262
|
$206,701,010,000 | 15.55% |
| Tempus Ai Inc |
Opened
4,572,810
|
$160,048,350,000 | 12.04% |
| Rhythm Pharmaceuticals Inc. |
No change
2,909,956
|
$119,482,793,000 | 8.99% |
| Mirum Pharmaceuticals Inc |
Closed
4,186,243
|
$100,553,557,000 | |
| Savara Inc |
1.38%
24,471,264
|
$98,619,194,000 | 7.42% |
| Coursera, Inc. |
No change
12,867,769
|
$92,133,226,000 | 6.93% |
| Ionq Inc |
Closed
14,614,829
|
$89,881,198,000 | |
| CRISPR Therapeutics AG |
No change
1,587,854
|
$85,759,995,000 | 6.45% |
| Verona Pharma Plc |
No change
5,584,753
|
$80,755,528,000 | 6.08% |
| Cloudflare Inc |
Closed
1,249,215
|
$77,026,597,000 | |
| Nextnav Inc |
No change
8,189,156
|
$66,414,055,000 | 5.00% |
| Berkshire Grey Inc |
Closed
38,183,023
|
$52,692,572,000 | |
| Bright Health Group Inc. |
Closed
218,153,623
|
$48,059,242,000 | |
| Korro Bio Inc |
Opened
1,090,793
|
$36,945,159,000 | 2.78% |
| Trevi Therapeutics, Inc. |
No change
11,370,376
|
$33,883,720,000 | 2.55% |
| Desktop Metal, Inc. |
Closed
14,398,927
|
$33,117,532,000 | |
| Monte Rosa Therapeutics Inc |
No change
7,692,298
|
$28,769,195,000 | 2.16% |
| Cvrx Inc |
No change
2,370,542
|
$28,422,799,000 | 2.14% |
| Zerofox Hldgs Inc |
Closed
18,068,513
|
$26,380,029,000 | |
| Aurinia Pharmaceuticals Inc |
No change
3,969,834
|
$22,667,752,000 | 1.71% |
| Nkarta, Inc. |
No change
3,568,781
|
$21,091,496,000 | 1.59% |
| Black Diamond Therapeutics Inc |
29.00%
4,448,757
|
$20,731,208,000 | 1.56% |
| Celcuity Inc |
No change
1,250,001
|
$20,475,016,000 | 1.54% |
| Phathom Pharmaceuticals Inc |
Opened
1,960,169
|
$20,189,741,000 | 1.52% |
| Buzzfeed Inc |
Closed
15,333,892
|
$17,327,298,000 | |
| Adaptimmune Therapeutics Plc |
0.00%
17,079,778
|
$16,651,076,000 | 1.25% |
| Gossamer Bio, Inc. |
421.80%
18,093,034
|
$16,300,014,000 | 1.23% |
| CTI BioPharma Corp |
Closed
3,685,683
|
$15,479,869,000 | |
| Neuehealth Inc |
Opened
2,726,917
|
$14,834,428,000 | 1.12% |
| Geron Corp. |
86.99%
2,776,409
|
$11,771,974,000 | 0.89% |
| Regulus Therapeutics Inc |
347.56%
6,467,802
|
$11,577,366,000 | 0.87% |
| Inozyme Pharma, Inc. |
No change
2,437,689
|
$10,872,093,000 | 0.82% |
| Oric Pharmaceuticals, Inc. |
Opened
1,500,000
|
$10,605,000,000 | 0.80% |
| Buzzfeed Inc |
Opened
3,833,473
|
$10,580,385,000 | 0.80% |
| Mynd Ai Inc |
Opened
3,642,711
|
$10,090,309,000 | 0.76% |
| Champions Oncology Inc |
No change
1,713,720
|
$8,859,932,000 | 0.67% |
| X4 Pharmaceuticals, Inc. |
27.69%
14,986,793
|
$8,692,340,000 | 0.65% |
| Reneo Pharmaceuticals Inc |
No change
4,785,494
|
$7,226,096,000 | 0.54% |
| Sagimet Biosciences Inc |
Opened
2,000,275
|
$6,840,941,000 | 0.51% |
| Minerva Surgical Inc |
Closed
34,437,052
|
$6,803,040,000 | |
| Allakos Inc |
No change
6,147,260
|
$6,147,260,000 | 0.46% |
| GlycoMimetics Inc |
Closed
4,764,440
|
$6,003,194,000 | |
| Desktop Metal, Inc. |
Opened
1,439,892
|
$5,946,754,000 | 0.45% |
| Marker Therapeutics, Inc. |
No change
1,071,428
|
$5,817,854,000 | 0.44% |
| Tuya Inc. |
33.92%
3,260,976
|
$5,576,269,000 | 0.42% |
| Acrivon Therapeutics Inc |
Closed
481,677
|
$4,889,985,000 | |
| Synlogic Inc |
Opened
2,922,772
|
$4,384,158,000 | 0.33% |
| Inventiva Sa |
No change
1,462,586
|
$4,373,132,000 | 0.33% |
| Lexicon Pharmaceuticals Inc |
No change
2,382,286
|
$4,002,240,000 | 0.30% |
| Affimed Nv |
Closed
4,426,488
|
$3,300,389,000 | |
| Synlogic Inc |
Closed
4,228,940
|
$2,672,690,000 | |
| Affimed Nv |
Opened
442,649
|
$2,412,432,000 | 0.18% |
| Satsuma Pharmaceuticals, Inc. |
Closed
2,294,095
|
$1,602,425,000 | |
| Senti Biosciences Inc |
5.83%
4,426,151
|
$1,221,618,000 | 0.09% |
| Addex Therapeutics Ltd |
Closed
5,648,690
|
$1,112,792,000 | |
| Eargo, Inc. |
Closed
226,000
|
$1,057,680,000 | |
| Airspan Networks Holdings Inc |
Closed
1,359,842
|
$941,419,000 | |
| Ikena Oncology Inc |
Opened
570,050
|
$940,583,000 | 0.07% |
| Wheels Up Experience Inc |
Closed
1,108,371
|
$681,563,000 | |
| Fiscalnote Holdings Inc |
Closed
307,344
|
$576,166,000 | |
| ObsEva SA. |
Closed
4,586,563
|
$499,935,000 | |
| Wheels Up Experience Inc |
Opened
106,125
|
$200,576,000 | 0.02% |
| Akari Therapeutics Plc |
Closed
452,167
|
$82,159,000 | |
| Palo Alto Networks Inc |
Closed
78
|
$15,580,000 | |
| No transactions found | |||
| Showing first 500 out of 64 holdings | |||
Hedge funds similar to Nea Management
- First American Bank
- Siemens Fonds Invest Gmbh
- Geller Advisors
- Cadence Bank
- Pfg Advisors
- Transform Wealth
- Galileo (ptc) Ltd
- Hps Investment Partners
- Schechter Investment Advisors
- Partners Ag
- Alerus Financial Na
- Simmons Bank
- Atwood & Palmer Inc
- Harvard Management Co Inc